Red Light Therapy for Beginners: What It Does, How to Use It, and What to Buy

Red light therapy (photobiomodulation) uses low-level red and near-infrared wavelengths — typically 630–850 nm — to stimulate mitochondrial function, primarily via cytochrome c oxidase. Human research suggests potential benefits for skin quality, muscle recovery, and joint comfort. Evidence quality varies across applications: skin and wound healing have the strongest human study support, while other areas require further investigation. No disease treatment claims can be made.

Key Takeaways

• Red light therapy uses specific wavelengths (630–850 nm) to penetrate skin and stimulate mitochondria; the primary mechanism involves cytochrome c oxidase in the electron transport chain.¹
• Among the applications studied in humans, skin rejuvenation and intradermal collagen density have the strongest RCT support, with one 136-volunteer controlled trial reporting significant improvements in skin roughness and collagen density.²
• Multiple systematic reviews suggest that photobiomodulation is associated with improved muscle performance and reduced exercise-induced fatigue when applied before or after exercise, though results vary across study protocols.³
• A 2024 systematic review with meta-analysis (10 studies, 542 participants) found PBM was associated with reduced pain and disability in knee osteoarthritis, with moderate certainty of evidence.⁴
• A small RCT in elite athletes found 14 days of whole-body red light exposure was associated with improved sleep quality scores and higher serum melatonin levels, though sample size was limited.⁵
• Key device specifications to evaluate include irradiance (mW/cm²), verified wavelength accuracy, treatment coverage area, and the presence of third-party testing documentation.
• Standard beginner protocols involve 10–20 minute sessions, 3–5 times per week, at a distance of 15–30 cm from the device, with eye protection recommended throughout.

What Is Photobiomodulation? The Science Explained Simply

Photobiomodulation (PBM) is the scientific term for what is commonly marketed as red light therapy or low-level laser therapy (LLLT). The term refers to the use of low-energy red or near-infrared (NIR) light to stimulate biological processes in cells and tissue. Unlike ultraviolet light, which can damage DNA, or intense laser systems used in surgery, photobiomodulation uses wavelengths and power levels that do not generate significant heat or cause thermal damage to tissue.

The field has its origins in research by Hungarian physician Endre Mester in 1967, who observed that low-power laser light appeared to accelerate wound healing in mice. Over the following decades, researchers identified the primary cellular mechanism: specific wavelengths of red and near-infrared light are absorbed by a mitochondrial enzyme called cytochrome c oxidase (CCO), the terminal enzyme in the electron transport chain responsible for oxygen utilisation during cellular energy production.¹

Red Light vs Near-Infrared: What Is the Difference?

The two main wavelength ranges used in photobiomodulation devices serve slightly different purposes due to their different tissue penetration depths.

Red light (630–700 nm) penetrates to the superficial layers of skin and is primarily relevant for surface-level applications, including skin quality, wound healing, and superficial tissue. It is visible to the human eye as a deep red colour.

Near-infrared light (800–850 nm) is invisible to the human eye and penetrates more deeply — potentially reaching muscle tissue, joints, and deeper structures beneath the skin. This makes NIR wavelengths particularly relevant for applications involving deeper tissue targets, including muscle recovery and joint comfort.

Many home-use devices combine both wavelength ranges to address both superficial and deeper tissue targets simultaneously. Research suggests that both ranges interact with cytochrome c oxidase, though the precise absorption peaks differ between the two.¹

How the Mechanism Is Understood

The leading hypothesis for how photobiomodulation produces biological effects involves the following sequence: red or NIR photons are absorbed by cytochrome c oxidase in the mitochondrial inner membrane. This absorption is associated with changes in the enzyme's activity and may involve displacement of inhibitory nitric oxide from the enzyme's active site, which in turn allows normal electron transport chain function to resume. Secondary effects include modest changes in ATP synthesis, reactive oxygen species levels, and nitric oxide signalling, which then influence downstream cellular responses including gene expression, inflammation regulation, and cell survival pathways.¹

It is important to note that the mechanistic picture is not fully resolved. Some researchers have highlighted that not all biological effects of PBM appear to require CCO, and additional chromophores including light-gated ion channels may also play a role. The field acknowledges this complexity. What is better established is the biphasic dose response: lower doses of light tend to produce stimulatory effects, while excessive doses can have neutral or inhibitory effects. This is a consideration when evaluating device output and protocol design.

What Human Research Shows: Skin, Recovery, and Beyond

The human evidence base for photobiomodulation spans a range of applications. The quality and volume of evidence differ considerably across these areas. Below is a review of the most studied outcomes, presented with appropriate context about study limitations.

Skin Quality and Collagen Density

Skin is among the best-studied applications for red light therapy, partly because the relevant tissue is directly accessible to the wavelengths used. Randomised controlled trials in this area have assessed outcomes including skin roughness, wrinkle depth, collagen density, and patient-reported satisfaction.

A prospective, randomised, controlled trial enrolled 136 volunteers who were assigned to red light (611–650 nm), broadband polychromatic light (570–850 nm), or a control condition. Participants received twice-weekly sessions across 30 treatments. Compared with baseline and controls, the treated groups showed significant improvements in self-assessed skin feeling and complexion, profilometrically measured skin roughness, and ultrasonographically measured intradermal collagen density. Blinded evaluators assessing clinical photographs also confirmed significant improvement in the red-light groups. The study noted a tendency for greater collagen density increases in female participants compared with male, suggesting potential gender-specific variation in response.²

The proposed mechanism involves stimulation of dermal fibroblasts, which are the primary collagen-producing cells in the skin. Red wavelengths that penetrate to the dermis appear to stimulate fibroblast activity and upregulate collagen synthesis pathways, alongside changes in matrix metalloproteinase expression that support the remodelling and replacement of fragmented, aged collagen with new structural collagen fibres.¹

Overall, skin rejuvenation and intradermal collagen density represent the application area with the most consistent human RCT support. Study sample sizes remain modest, and longer-term durability data is limited. But the direction of evidence is relatively clear for these outcomes.

Muscle Recovery and Exercise Performance

A substantial volume of human research has examined photobiomodulation in the context of exercise, with outcomes including muscle fatigue, force output, time to exhaustion, and biochemical markers of muscle damage such as creatine kinase (CK) and lactate dehydrogenase (LDH).

A systematic review and meta-analysis published in 2017, which searched PubMed, PEDro, Cochrane Library, EMBASE, and Web of Science databases through March 2017, synthesised data from randomised clinical trials investigating PBM for muscle performance and fatigue in healthy people. The analysis found that pre-exercise application of PBM was associated with improvements in several performance outcomes, including fatigue resistance and time to exhaustion, as well as reduced post-exercise CK levels, when appropriate wavelengths and doses were used. The review also noted significant variability in light parameters across studies and cautioned that this variability made definitive dose recommendations difficult.³

A further review covering human clinical trials in sports performance contexts through 2016 concluded that photobiomodulation, particularly when applied as muscular preconditioning before exercise, showed positive effects in a majority of included RCTs for outcomes including fatigue resistance, muscle force, and markers of muscle damage. The review identified total energy applied and coverage of the muscle group as factors associated with more positive outcomes.⁶

It is worth noting that results in this area are not uniform. Some trials using different protocols have reported no significant benefit, and findings are sensitive to the timing of application, wavelength, dose, and the specific muscle groups and exercise modalities studied. Readers should not interpret positive findings from one protocol as universally applicable.

Joint Pain and Comfort

The evidence for photobiomodulation in joint-related applications has grown considerably, with knee osteoarthritis being the most studied condition in rigorous human trials.

A 2024 systematic review with meta-analysis searched PubMed, EMBASE, Web of Science, and Cochrane databases through October 2023 and included 10 randomised placebo-controlled trials comprising 542 participants with knee osteoarthritis. The pooled analysis found that PBM was associated with reduced pain scores and improved disability outcomes compared with placebo, with the authors grading the certainty of evidence for reduced disability as moderate. The review used the Cochrane Risk of Bias tool (version 2) and GRADE framework to evaluate evidence quality.⁴

An umbrella review of meta-analyses of RCTs published in 2024 — which synthesised findings across 15 meta-analyses covering more than 9,000 patients and 15 unique health outcomes — identified knee osteoarthritis disability as one of five outcomes supported by moderate certainty of evidence for improvement with PBM. The same umbrella review found no outcomes supported by high certainty evidence, reflecting the field's overall state of evidence maturity.¹

Sleep Quality

Sleep represents an emerging area of interest for photobiomodulation research. The mechanistic rationale involves the relationship between red light and melatonin: unlike blue and white light, which suppress melatonin production via retinal photoreceptors, red wavelengths do not appear to interfere with normal melatonin signalling, and may in some contexts be associated with changes in serum melatonin levels.

A randomised controlled trial enrolled 20 elite female basketball athletes who were assigned to either whole-body red light irradiation (658 nm, 30 J/cm², 30 minutes per night for 14 consecutive days) or a placebo group. Participants completed the Pittsburgh Sleep Quality Index (PSQI) and provided serum melatonin samples at baseline and post-intervention. The study reported significant improvements in PSQI scores and serum melatonin levels in the red light group compared with placebo, as well as a significant correlation between PSQI score changes and melatonin level changes. Endurance performance in a 12-minute run test also improved in the treated group. The study was limited by its small sample size (10 per group) and the specific population studied (elite athletes under high training load), which limits generalisation to other populations.⁵

A more recent randomised, sham-controlled trial in 30 adults (aged 30–60) with self-reported sleep complaints used a wearable cervical device emitting combined red and near-infrared wavelengths (660, 740, 810, and 870 nm) every other night before bed over three weeks. Objective sleep parameters measured by actigraphy did not differ significantly between active and sham groups, though participants in the active group reported improved subjective sleep quality and perceived daytime functioning. The authors noted the need for further research to optimise dose parameters and wavelength selection for this application.⁷

Sleep research in this field is promising but early-stage. Existing studies involve small samples, heterogeneous populations, and varying device parameters. At this time, sleep quality represents an area of active investigation rather than a firmly established application.

How to Use Red Light Therapy: A Practical Protocol

For those using a home photobiomodulation device, the following practical guidelines reflect current protocols reported in the human research literature. These are educational parameters and not medical instructions.

Distance from the Device

The effective irradiance (light energy reaching the skin per unit area, measured in mW/cm²) decreases rapidly as distance from the device increases, following an inverse-square relationship. Most panel manufacturers specify the irradiance at a given distance, typically 15 cm and 30 cm. For users targeting surface-level skin outcomes, positioning closer to the device (15–20 cm) may be appropriate. For deeper tissue targets such as larger muscle groups, panels with higher total power output are more relevant, as irradiance must be sufficient to penetrate the target tissue depth.

A practical starting point for most beginners is 15–30 cm from the device. Always follow the manufacturer's specific distance recommendations, as output varies substantially between products.

Session Duration

Most research protocols use session durations of 10–20 minutes per treatment area. Longer sessions do not necessarily produce better results due to the biphasic dose response described above: excessive cumulative energy can produce neutral or counterproductive effects. Beginning with shorter sessions of 10–12 minutes and observing individual response before progressing to 20-minute sessions is a reasonable approach for beginners.

Frequency

Research protocols typically employ 3–5 sessions per week. Daily use is used in some acute recovery and wound healing protocols, but for general maintenance use by healthy adults, 3–4 sessions per week is a common starting point. Consistency over time matters more than any single session.

Clothing and Skin Preparation

For treatment to be effective, the skin must be exposed directly. Clothing blocks the relevant wavelengths. Remove clothing from the area being treated and clean the skin of any thick topical products, such as opaque sunscreen or heavy moisturisers, that may block light penetration.

Eye Protection

While red and near-infrared wavelengths are not UV-range radiation, direct exposure of the eyes to high-intensity light sources is not advisable. Most devices include or recommend protective goggles for use during sessions. Use them consistently, particularly when treating the face or head area.

Timing: Morning vs Evening

Timing considerations differ by application goal. For recovery and general performance applications, morning or pre-exercise timing aligns with most positive RCT protocols. For potential sleep-related benefits, evening use of red-wavelength-dominant devices has been explored in the research literature and is considered less disruptive to circadian signalling than blue-rich light. If using near-infrared wavelengths in the evening, note that some devices also contain red wavelengths that may have different circadian effects compared with NIR alone.

Common Beginner Mistakes

The most common mistakes beginners make include: positioning too far from the device such that effective irradiance is insufficient; treating for excessive durations based on the assumption that more is better; using the device inconsistently and expecting rapid results from isolated sessions; and purchasing devices without verifying the actual irradiance output, wavelength accuracy, or the existence of third-party testing documentation.

What to Look for in a Red Light Therapy Device

The consumer market for red light therapy devices has expanded rapidly, and product quality varies considerably. The following specifications are the most important to evaluate before purchasing.

Irradiance (mW/cm²)

Irradiance is the measure of light intensity reaching the skin, expressed in milliwatts per centimetre squared. This is the most critical technical specification for assessing whether a device will deliver an effective light dose. Look for devices that clearly state irradiance at a specified distance. For reference, most research protocols use irradiances in the range of 20–200 mW/cm² at treatment distance. Be sceptical of devices that quote only total wattage without specifying irradiance at a measured distance, as total wattage alone does not determine effective dose.

Wavelength Accuracy

Devices should specify the exact wavelengths of their LEDs, not just broad categories like "red" or "NIR." Common effective wavelengths studied in human research include 630–660 nm for red and 810–850 nm for near-infrared. Third-party spectroscopy testing is the most reliable way to confirm that a device actually emits the stated wavelengths. Some budget devices emit wavelengths outside the biologically active range while still appearing red or invisible to the eye.

EMF Levels

Some users are concerned about electromagnetic field (EMF) emissions from LED panels. Higher-quality devices are often tested for EMF output. Look for devices that provide independent measurement data from third-party testing laboratories, rather than relying solely on manufacturer claims.

Coverage Area

Smaller handheld devices or targeted probe units cover limited areas and require repositioning during sessions. Panel devices offer broader coverage, making sessions more time-efficient for full-body or large-area applications. Larger modular panels or full-body setups provide the most comprehensive coverage and are used in whole-body research protocols.

Third-Party Testing and Certification

Credible devices come with independent testing documentation — Certificates of Analysis (COA) from recognised laboratories verifying spectral output, irradiance measurements, and safety compliance. This is the photobiomodulation device equivalent of third-party supplement testing. Reputable manufacturers make this documentation available on request. If a company is unable or unwilling to provide independent testing documentation for their device specifications, treat this as a significant quality concern.

At-Home Red Light Therapy on a Budget vs Premium Setup

The price range for red light therapy devices spans from under £150 for basic entry-level units to over £2,500 for large full-body panels from established brands. Understanding what each price tier realistically offers helps set appropriate expectations.

Entry Level (Under £200)

At this price point, devices are typically small-to-medium panels or handheld units with limited coverage area. Irradiance values are often lower than premium devices, and third-party testing documentation is less commonly available. Entry-level devices can be appropriate for targeted applications on small body areas (face, a single joint) if wavelengths and irradiance are verified. They are generally not suitable for whole-body protocols due to limited output and coverage.

Mid-Range (£400–£1,000)

This category includes larger panels with higher LED counts, better irradiance output, and typically more reliable wavelength specifications. Many devices at this tier include both red and near-infrared wavelengths. Some brands in this range provide third-party irradiance and spectral testing data. This price point is appropriate for users targeting multiple body areas or wanting more flexibility in session design. Look for brands that are transparent about irradiance figures at specified distances and provide documentation.

Premium (£1,500 and above)

Premium devices from established brands such as Joovv, PlatinumLED, and Mito Red occupy this tier. They typically offer the highest verified irradiance outputs, full-body panel configurations, comprehensive third-party testing documentation, and longer product warranties. Premium devices are appropriate for users who want to replicate whole-body research protocols, who value the assurance of independent verification, or who intend to use the device daily over several years. The value calculation depends on frequency and consistency of use.

Regardless of price tier, the most important purchasing filter is verified technical specifications from independent sources. A premium price tag does not automatically guarantee quality, and some mid-range brands have emerged with strong independent verification records. For a detailed comparison of specific leading brands, see our dedicated device comparison guide.

Q&A

What is the difference between red light therapy and infrared sauna?

Red light therapy (photobiomodulation) uses specific low-energy visible and near-infrared wavelengths in the range of 630–850 nm, delivered at low power densities that do not generate significant heat. The proposed mechanism involves photochemical interactions with mitochondrial enzymes. Infrared saunas primarily use longer wavelength infrared radiation (typically 3,000–100,000 nm) to generate heat in body tissue. The biological effects of infrared sauna are primarily thermally driven. They are distinct technologies with different mechanisms and different evidence bases.

Does red light therapy actually work, or is it just marketing?

The honest answer is: it depends on the application. For skin quality and intradermal collagen density, there are human RCTs with meaningful participant numbers showing consistent positive effects.² For muscle recovery and joint comfort, systematic reviews of RCTs show a positive trend, though with variability across studies. For some other applications marketed commercially, the human evidence base is much thinner or largely based on small, lower-quality studies. The technology has genuine scientific credibility for certain specific applications — but not all claims made in consumer marketing are equally supported.

Is red light therapy safe?

Within the parameters studied in clinical research, red and near-infrared light therapy has a well-established safety profile. It does not emit UV radiation, does not generate therapeutic-level heat, and serious adverse events have not been reported in well-conducted trials. The primary safety precaution is protecting the eyes from direct exposure to the light source. Individuals with photosensitising medical conditions or medications should consult a healthcare professional before use.

How long does it take to see results from red light therapy?

This depends on the application and individual factors. In the skin rejuvenation RCT reviewed above, measurements were taken after 30 treatment sessions conducted over approximately 15 weeks. Most research protocols run for 4–12 weeks before measuring outcomes. Effects from individual sessions are unlikely to be pronounced; cumulative and consistent use over weeks is what the research protocols demonstrate. Expecting visible results from a few sessions is not supported by the clinical literature.

Can I use red light therapy every day?

Daily use is used in some research protocols, particularly for wound healing and acute recovery applications. For general wellness use in healthy adults, 3–5 sessions per week is a more common research protocol. The biphasic dose response means that excessive cumulative dosing is not beneficial and may be counterproductive. Rest days between sessions allow cellular processes stimulated by PBM to complete. Starting at 3–4 sessions per week is a reasonable approach for most beginners.

What wavelengths are most effective?

The wavelengths with the strongest evidence base in human research are in the range of 630–670 nm (red) and 810–850 nm (near-infrared). These correspond to known absorption peaks of cytochrome c oxidase.¹ Wavelengths outside this range — such as green or yellow light — are used in some devices and may have their own biological effects, but are less studied in photobiomodulation research. Wavelengths marketed as "deep red" at 660 nm and "near-infrared" at 850 nm are both well-supported by existing research.

Do I need a prescription or professional device?

Consumer-grade devices are widely available without prescription in most countries. Professional clinical devices used by physiotherapists and healthcare practitioners differ primarily in output power, wavelength range, and documentation standards, but the underlying technology is the same. Professional-grade devices may achieve higher irradiance at the treatment site and offer more precise dosimetry control. For most general wellness applications, a well-verified consumer device at an appropriate irradiance is functionally comparable to lower-dose clinical protocols.

Does red light therapy have any effect on sleep?

A small RCT in elite athletes found that 14 nights of whole-body red light exposure was associated with improved sleep quality scores and higher serum melatonin compared with placebo.⁵ A separate sham-controlled trial in adults with sleep complaints found improvements in subjective but not objective sleep measures.⁷ Sleep represents an area of early-stage investigation with promising early signals but not yet robust evidence. The relevant observation is that red light does not suppress melatonin the way blue-rich light does, making it a more circadian-neutral evening light source than alternatives.

Frequently Asked Questions

References

1. Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics. 2017;4(3):337–361. View on PubMed ↗
2. Wunsch A, Matuschka K. A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase. Photomed Laser Surg. 2014;32(2):93–100. View on PubMed ↗
3. Ferraresi C, Huang YY, Hamblin MR. Photobiomodulation therapy for the improvement of muscular performance and reduction of muscular fatigue associated with exercise in healthy people: a systematic review and meta-analysis. Lasers Med Sci. 2017;33(1):181–214. View on PubMed ↗
4. Draper DO, et al. Effectiveness of Photobiomodulation in Reducing Pain and Disability in Patients With Knee Osteoarthritis: A Systematic Review With Meta-Analysis. Arthritis Care Res (Hoboken). 2024. View on PubMed ↗
5. Zhao J, Tian Y, Nie J, Xu J, Liu D. Red light and the sleep quality and endurance performance of Chinese female basketball players. J Athl Train. 2012;47(6):673–678. View on PubMed ↗
6. Ferraresi C, de Sousa MV, Huang YY, Bagnato VS, Parizotto NA, Hamblin MR. Photobiomodulation in human muscle tissue: an advantage in sports performance? Eur J Sport Sci. 2016;16(Suppl 1):S235–S245. View on PubMed ↗
7. Kennedy KER, Wills CCA, Holt C, Grandner MA. A randomized, sham-controlled trial of a novel near-infrared phototherapy device on sleep and daytime function. J Clin Sleep Med. 2023;19(9):1669–1675. View on PubMed ↗